Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2019-12-25
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Uniport VATS became a feasible option with the development of surgical techniques and instruments, with potentially less postoperative pain and shorter hospital stays. However, there may be some complications, or with a longer time of operation, even more difficult in lymph nodes resection during learning curve.
In our study, a Randomized Controlled Trial was designed to study the operation time, perioperative blood loss, conversion rate, duration of postoperative drainage, length of hospital stay, visual analogue score of postoperative pain, complications, and survival.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer
NCT02462356
Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer
NCT03331588
Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer
NCT02933294
Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer
NCT02992353
Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer
NCT03997799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single port group
Uniport video-assisted thoracoscopic surgery for NSCLC
uniport video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using single port or two ports or three ports
two ports group
video-assisted thoracoscopic surgery for NSCLC using two ports
two ports video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using two ports
three ports group
video-assisted thoracoscopic surgery for NSCLC using three ports
three ports video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using three ports
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uniport video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using single port or two ports or three ports
two ports video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using two ports
three ports video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using three ports
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Second Hospital of Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaogang Zhao, Doctor
Role: STUDY_DIRECTOR
The Second Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Second Hospital of Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yunpeng Zhao, doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uniport VATS ZYP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.